Old Web
English
Sign In
Acemap
>
Paper
>
210 Should immunosuppressive therapy (1ST) be used more often in lower risk MDS
210 Should immunosuppressive therapy (1ST) be used more often in lower risk MDS
2011
Sophie Cereja
Sabine Brechignac
L. Ades
Thorsten Braun
S. Boehrer
Z. Hebibi
Rosa Sapena
Odile Beyne-Rauzy
N. Vey
Hervé Dombret
D. Bordessoule
Francois Dreyfus
P. Fenaux
C. Gardin
Keywords:
Cancer research
Immunology
Lower risk
Biology
Internal medicine
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]